Adherence to antiretroviral therapy and treatment outcomes among conflict-affected and forcibly displaced populations: a systematic review

Conflict and Health

David A Ross¹  Paul Spiegel²  Marian Schilperoord²  Joshua B Mendelsohn¹ 

[1] Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, MRC Tropical Epidemiology Group, London, UK;Public Health and HIV Unit, United Nations High Commissioner for Refugees, Geneva, Switzerland

关键词: Systematic review;    Adherence;    Conflict;    Refugees;    Forced migration;    Treatment outcomes;    Antiretroviral therapy;   

Others  :  810362
DOI  :  10.1186/1752-1505-6-9

 received in 2012-05-25, accepted in 2012-10-21,  发布年份 2012

【 授权许可】

   
2012 Mendelsohn et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]International Federation of Red Cross and Red Crescent Societies: World Disaster Report 2008: Focus on HIV and AIDS. Geneva, Switzerland: International Federation; 2008:118-141.
• [2]O'Brien DP, Venis S, Greig J, Shanks L, Ellman T, Sabapathy K, Frigati L, Mills C: Provision of antiretroviral treatment in conflict settings: the experience of Médecins Sans Frontières. Confl Health 2010, 4:12. BioMed Central Full Text
• [3]Mills EJ, Ford N, Singh S, Eyawo O: Providing antiretroviral care in conflict settings. Curr HIV/AIDS Rep 2009, 6:201-209.
• [4]Convention relating to the Status of Refugees. http://www.unhcr.org/refworld/docid/3be01b964.html webcite
• [5]Handbook for the Protection of Internally Displaced Persons. http://www.unhcr.org/refworld/docid/4790cbc02.html webcite
• [6]Uppsala Conflict Data Program Conflict Encyclopedia. http://www.pcr.uu.se/research/ucdp/definitions/#Active webcite
• [7]Definitions of Fragility and Conflict. http://web.worldbank.org/WBSITE/EXTERNAL/PROJECTS/STRATEGIES/EXTLICUS/0, contentMDK:22230573~pagePK:64171531~menuPK:4448982~piPK:64171507~theSitePK:511778,00.html webcite
• [8]Strand H, Dahl M: Paper commissioned for the EFA Global Monitoring Report 2011, The hidden crisis: armed conflict and education. Paris, France: UNESCO; 2010.
• [9]Statistical Yearbook 2010. http://www.unhcr.org/statistics webcite
• [10]Select Fact and Figures on Fragility and Conflict. http://web.worldbank.org/WBSITE/EXTERNAL/PROJECTS/STRATEGIES/EXTLICUS/0, contentMDK:22934897~pagePK:64171531~piPK:64171507~theSitePK:511778,00.html webcite
• [11]Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
• [12]Kiboneka A, Nyatia RJ, Nabiryo C, Anema A, Cooper CL, Fernandes KA, Montaner JS, Mills EJ: Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda. BMJ 2009, 338:b201.
• [13]Garang PG, Odoi RA, Kalyango JN: Adherence to antiretroviral therapy in conflict areas: a study among patients receiving treatment from Lacor Hospital, Uganda. AIDS Patient Care STDS 2009, 23:743-747.
• [14]Feikin DR, Adazu K, Obor D, Ogwang S, Vulule J, Hamel MJ, Laserson K: Mortality and health among internally displaced persons in western Kenya following post-election violence, 2008: novel use of demographic surveillance. Bull World Health Organ 2010, 88:601-608.
• [15]O'Brien DP, Mills C, Hamel C, Ford N, Pottie K: Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo. Confl Health 2009, 3:1. BioMed Central Full Text
• [16]Culbert H, Tu D, O'Brien DP, Ellman T, Mills C, Ford N, Amisi T, Chan K, Venis S: HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo. PLoS Med 2007, 4:e129.
• [17]Salami O, Buzu A, Nzeme C: High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan. J Int AIDS Soc 2010, 13:123. BioMed Central Full Text
• [18]McCarthy K, Chersich MF, Vearey J, Meyer-Rath G, Jaffer A, Simpwalo S, Venter WDF: Good treatment outcomes among foreigners receiving antiretroviral therapy in Johannesburg, South Africa. Int J STD AIDS 2009, 20:858-862.
• [19]Pyne-Mercier LD, John-Stewart GC, Richardson BA, Kagondu NL, Thiga J, Noshy H, Kist N, Chung MH: The consequences of post-election violence on antiretroviral HIV therapy in Kenya. AIDS Care 2011, 23:562-568.
• [20]Beckwith CG, DeLong AK, Desjardins SF, Gillani F, Bazerman L, Mitty JA, Ross H, Cu-Uvin S: HIV infection in refugees: a case–control analysis of refugees in Rhode Island. Int J Infect Dis 2009, 13:186-192.
• [21]Nisbet SM, Reeve AM, Ellis-Pegler RB, Woodhouse AF, Ingram RJ, Roberts SA, McAllister SM, Thomas MG: Good outcome in HIV-infected refugees after resettlement in New Zealand: population study. Intern Med J 2007, 37:290-294.
• [22]Moreno A, Crosby S, Labelle C, Sullivan M, Samet JH: Health assessment of HIV-infected refugees. J Acquir Immune Defic Syndr 2003, 34:251-254.
• [23]Krentz H, Gill MJ: The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes in a regional Canadian HIV population. Health Policy 2009, 90:296-302.
• [24]Blood E, Beckwith C, Bazerman L, Cu-Uvin S, Mitty J: Pregnancy among HIV-infected refugees in Rhode Island. AIDS Care 2009, 21:207-211.
• [25]Rutta E, Gongo R, Mwansasu A, Mutasingwa D, Rwegasira V, Kishumbu S, Tabayi J, Masini T, Ramadhani H: Prevention of mother-to-child transmission of HIV in a refugee camp setting in Tanzania. Glob Publ Health 2008, 3:62-76.
• [26]Olupot-Olupot P, Katawera A, Cooper C, Small W, Anema A, Mills E: Adherence to antiretroviral therapy among a conflict-affected population in Northeastern Uganda: A qualitative study. AIDS 2008, 22:1882-1884.
• [27]Wilhelm-Solomon M: Social networks and sustainable antiretroviral provision to displaced communities in northern Uganda. Trop Med Int Health 2009, 14:35-36.
• [28]Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodriguez E, Warren MR, Vejo J: Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav 2011, 15:1381-1396.
• [29]Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, et al.: Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006, 296:679-690.
• [30]Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C: Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006, 3:e438.
• [31]Akileswaran C, Lurie MN, Flanigan TP, Mayer KH: Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis 2005, 41:376-385.
• [32]Pai NP, Lawrence J, Reingold AL, Tulsky JP: Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults. Cochrane Database Syst Rev 2006, 3:CD006148.
• [33]Pai NP, Tulsky JP, Lawrence J, Colford JM Jr, Reingold AL: Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults. Cochrane Database Syst Rev 2005, 4:CD005482.
• [34]El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, et al.: CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006, 355:2283-2296.
• [35]Kranzer K, Ford N: Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Trop Med Int Health 2011, 10:1297-1313.
• [36]Chesney MA: The elusive gold standard - future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr 2006, 43:S149-S155.
• [37]Nachega JB, Mills EJ, Schechter M: Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS 2010, 5:70-77.
• [38]Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, Orrell C, Altice FL, Bangsberg DR, Bartlett JG, et al.: Guidelines for improving entry into and retention in care and antiretroviral adherence for persons With HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med 2012, 156:817-833.
• [39]Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff CE, et al.: HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multitcentre observational study. Lancet Infect Dis 2011, 11:750-759.
• [40]Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, De Cock K: The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006, 368:505-510.
• [41]Adlington R, Richens J, Shahmanesh M: First-line antiretroviral therapy in resource-limited settings: time to reconsider? J Infect Dis 2009, 199:1407. author reply 1407–1408
• [42]Chung MH, Richardson BA, Tapia K, Benki-Nugent S, Kiarie JN, Simoni JM, Overbaugh J, Attwa M, John-Stewart GC: A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med 2011, 8:e1000422.
• [43]Lester RT, Ritvo P, Mills EJ, et al.: Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010, 376:1838-1845.
• [44]Médecins Sans Frontières: Providing antiretroviral therapy for mobile populations: lessons learned from a cross border ARV program in Musina. South Africa. Cape Town: Médecins Sans Frontières; 2012.
• [45]UNHCR: Protracted refugee situations - Standing Committee 30th Meeting. Geneva: UNHCR; 2004.
• [46]Ford N: Treating AIDS in complex emergencies: the need for clear policy consensus. Prog Dev Stud 2009, 9:55-61.